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ABSTRACT  
 
Background: Aiming at the harmonization and establishment of common standards in the 
neuropsychological assessment of surgical patients with epilepsy, the current practice in 
European epilepsy centers was evaluated. 
Method: Twenty-six epilepsy centers joining “E-PILEPSY”, an EU funded pilot network of 
European reference centers for drug resistant epilepsy and epilepsy surgery, were asked to 
report the status of neuropsychological assessment in adults and children via two different 
surveys. 
Results: It was agreed that neuropsychology is an essential part of presurgical work-up. 
Large agreement was found on indications (localization, epileptic dysfunctions, adverse 
drugs effects, postoperative monitoring) and the domains to be evaluated (memory, 
attention, executive functions, language, visuo-spatial skills, intelligence, depression, anxiety, 
and quality of life). Although 186 different tests are in use, a core group of tests reflecting 
minimal agreement could be discerned. Variability exists with regard to indications, protocols 
and paradigms for the assessment of hemispheric language dominance. For the tests in use, 
little published evidence of clinical validity in epilepsy was provided. Participants of the 
survey reported a need for improvements concerning the validity of the tests, tools for the 
assessment of everyday functioning and accelerated forgetting, national norms and test co-
normalization. 
Conclusion: Based on this survey, a consensus on the indications and principles of 
neuropsychological testing was achieved. Despite the variety of tests in use, the survey 
indicated there may be a core set of tests which appear to result from experience as well as 
published evidence. By combining with the results of an ongoing systematic literature review, 
we aim for a battery which can be recommended for the use across epilepsy surgical centers 
in Europe.  
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 1. Introduction 
 
In January 2014, a European pilot network of reference centers in drug resistant epilepsy 
and epilepsy surgery, funded by the European Union in the framework of the Health Program 
(http://www.e-pilepsy.eu), was established. The primary objective is to improve the quality, 
accessibility and harmonization of presurgical diagnostic approaches in patients with drug 
resistant focal epilepsy across Europe. One aim of this network is to describe the 
requirements and the structure of epilepsy surgical centers and of current practice in brain 
imaging, source localization procedures [1], EEG monitoring [2] and, what will be dealt with 
here, the neuropsychological assessment and outcome monitoring in patients with drug 
resistant epilepsy.  
 
Epilepsy surgery is an elective procedure with the ultimate goal of improving the individual 
health-related quality of life through sustained seizure-freedom or improvement. At the same 
time, successful epilepsy surgery aims at preservation or even improvement of the patients’ 
functional capabilities, mood and behavior, thereby improving their socio-economic 
opportunities and quality of life. In the context of epilepsy surgery, neuropsychology aims to 
identify epilepsy-related cognitive impairments and their etiological attribution to lesions, the 
active epilepsy, drug treatment, and mood within a neuropsychological developmental 
framework which takes age at onset and the brain’s capacity for reorganization and 
compensation into consideration [3].  
 
Epilepsy surgery can be associated with cognitive decline. Before surgery, up to 80% of 
patients already show cognitive impairment in at least one neuropsychological domain [4].  
After temporal lobe resections, the most frequent type of surgery, up to 45% may experience 
a decline in memory [5, 6]. Furthermore, in terms of complications, surgery can lead to new 
cognitive deficits or an unexpectedly severe deterioration of cognition, for example disabling 
memory deficits after temporal lobe surgery [7]. In children, surgery has an impact on 
postsurgical cognitive development, which is often positive [8]. Surgically caused 
impairments are especially intolerable in the absence of postsurgical seizure freedom [9, 10]. 
As such, it is important to individually predict postsurgical deficits to a certain degree. Major 
predictors of neuropsychological outcome include the presurgical performance, reflecting 
functional integrity of the resected tissues on the one hand, and reserve capacities of non-
affected brain structures on the other hand. Additional predictors are cerebral functional 
plasticity, seizure control and the burden of antiepileptic drug treatment [6, 11-14]. 
Neuropsychological examinations after surgery help to objectively quantify cognitive 
outcomes, indicate the need for rehabilitative care, and, in terms of quality control, help to 
optimize treatment outcome of resective epilepsy surgery with minimal cognitive risks [6, 15].  
 
Apart from cognitive problems, affective problems such as depression and anxiety in adults 
as well as autism and attention deficit hyperactivity disorder (ADHD) in children are very 
frequent [16]. Affective problems are seen in up to 50% of surgical candidates and – similar 
to cognitive and behavioral problems – in part result from epilepsy and its treatment, and in 
part may share the same underlying pathophysiology with the epilepsy [17]. They are often 
under-diagnosed and need to be considered and treated [18]. On a superordinate level 
quality of life has been identified as a relevant outcome parameter [19]. 
 
The aforementioned aspects are all central to be assessed and evaluated in the context of 
epilepsy surgery. This survey describes how this is being achieved in different reference 
centers for epilepsy surgery across Europe. While the neuropsychology task force of the 
International League against Epilepsy (ILAE) has recently updated the concepts and 
principles of neuropsychological assessments in epilepsy [20], detailed information about 
which tests to use is less easy to obtain. Earlier surveys 23 years [21], 11 years [22] and five 
years ago [23, 24] indicate that there is a wide range of neuropsychological tests used in 
different epilepsy clinics, not to mention in different countries [25]. In a review of the 
theoretical and practical issues of neuropsychology in epilepsy we postulated an exemplary 
evidence-based, question guided and modular approach which is not only descriptive but can  
make a difference for patients and their treatment [26]. For the purpose of E-PILEPSY, 
however, such a model needs to be filled with content which is acceptable not only on a 
national basis [27, 28] but across different centers in different countries.  
Communication of the neuropsychological features of patient groups, of surgical methods 
and their outcomes across centers and countries calls for a common language. This requires 
a harmonization of procedures. These procedures need to meet certain methodological 
criteria such as age-corrected normative data, standardization for repeated measurement, 
and sensitivity to the factors causing cognitive impairments in epilepsy.  
 
One central and explicit aim of the E-PILEPSY project is to harmonize best practice in 
epilepsy surgery and develop guidelines and recommendations based on best available 
evidence. Given historical and legal reasons but also cultural and linguistic diversities, it is an 
ambitious undertaking to strive for a European standard. As a first step, the current practice 
in the E-PILEPSY associated reference centers needs to be documented. In order to obtain 
that information we conducted a survey among all centers participating in the E-PILEPSY 
project. The second step, which has already been initiated and which will be dealt with in 
subsequent publications, is a systematic review of the existing literature in order to discern 
which instruments may best serve the objectives of neuropsychology in the context of 
epilepsy surgery. In a third step a selection of tests will be made which then requires efforts 
of normalization and standardization for repeated measurement in each associated 
European country. In parallel, work on a common web-based database, which will provide 
tests, materials and normative data, is in progress.  
 
2. Methods 
 
Two separate surveys were sent out electronically to 26 epilepsy surgery centers of the E-
PILEPSY network (21 countries, 19 languages: Austria Salzburg, Belgium Gent, Bulgaria 
Sofia, Croatia Zagreb, Czech Republic, Prague, Finland Kuopio, France ?, Germany Bonn 
and Kork, Greece Thessaloniki, Hungary Budapest, Italy Milano, Lithuania Vilinus, 
Netherlands Utrecht, Norway Oslo, Romania Bucharest, Russia Moscow, Spain Madrid, 
Sweden Goteborg, Switzerland Genf, Turkey Istanbul, UK London). The first survey focused 
on neuropsychological testing per se and was – in part – similar to the German inquiry in 
2008[29]. The focus was in interictal, pre- and postsurgical assessment of patients with 
epilepsy, not on bed-side, ictal testing. The second inquiry was related to the assessment of 
hemispheric dominance for language functions. The surveys were launched in February 
2014 and concluded in June 2015. The first survey consisted of 29 questions addressing the 
neuropsychological assessment per se. The questions comprised multiple choice answers 
and/or free text fields and covered the following areas: Availability of epilepsy surgery and of 
neuropsychological service for adults and children, implementation, organization and 
capacity of the neuropsychological service, indications for the neuropsychological 
assessment, consequences for clinical decision making and counseling, psychiatric 
assessment, as well as detailed descriptions of tests and questionnaires that are in use 
including published evidence for their use in patients with epilepsy. 
 
The second survey on the assessment of hemispheric dominance for language functions 
was sent out in August 2014 and concluded in June 2015. This questionnaire comprised 12 
items centering on the most common methods (IAT, intracarotid amobarbital test and fMRI, 
functional magnetic resonance imaging) and included one question on the general decision 
process of when and how to assess language dominance.  
 
The surveys were completed by neuropsychologists (n=14) or neurologists (n=11), with 
information provided by the neuropsychologists since they were no official participants in the 
project. 
We excluded our own center (Bonn) concerning one item of the survey asking for references 
of studies proving the validity of the neuropsychological tools for the use in epilepsy. The 
reason for this decision was that as coordinator of the survey, we wanted to avoid any bias. 
Many of the tests and questionnaires used in our center have been developed and/or 
validated by our own investigations. 
 
Descriptive statistics were performed using IBM SPSS 22. 
 
 
3. Results 
 
Completed questionnaires were received from 25 reference centers corresponding to a 
response rate of 96%.  
 
3. 1. Neuropsychological service   
 
Characteristics of the participating centers are shown in Table 1. Epilepsy surgery is 
performed in-house in 23/25 centers (in two cases, epilepsy patients are referred for surgery 
to a collaborating clinic after presurgical work-up). In-house neuropsychological assessment 
is available in 23/25 of the centers, two centers have external collaborating institutions. In 
those two centers without in-house neuropsychology, information derives from the 
collaborating institutions offering the neuropsychological service. All but one center regard 
the neuropsychological assessment as an important and indispensable part of the 
presurgical diagnostic work-up.  
 
please insert here: Table 1. Characteristics of participating centers 
 
While in six centers the neuropsychological service is focused only on those with epilepsy, 
most clinics provide their service additionally for neurological, neurosurgical and other patient 
groups. Psychiatric service is provided in 92% of the centers, the evaluation is performed 
exclusively by psychiatrists (60%), exclusively by psychologists (4%), both by psychologists 
and/or psychiatrists (28%), or both by psychiatrists and/or neurologists (4%). Standardized 
inventories for the assessment of depression, anxiety and other psychiatric symptoms are 
used by 75% (valid answers n=16). The average time needed for a full presurgical evaluation 
is 4.5 hours, ranging between 1.5 and 10 hours.  
 
3.2. Neuropsychological assessment 
 
Table 2 shows data on the specifications of the neuropsychological assessments. Indications 
for neuropsychological assessment included localizing (100%), in all cases presurgical 
(100%) and all but one centers postsurgical (96%) testing, the evaluation of general cognitive 
performance (92%), monitoring antiepileptic drug (AED) therapy (68%), testing for transient 
cognitive impairments (TCI) due to electroencephalographic epileptic discharges (56%), as 
well as for ictal (20%) and postictal (12%) deficits. 
 
Neuropsychological testing is used for clinical decision making i.e. for or against surgery 
(88%), to determine the extent of surgery (36%), to optimize antiepileptic drug treatment 
(32%), to determine the need for cognitive rehabilitation (32%) or for psychiatric treatment 
(24%). These answers were given in response to an open question, so these data might not 
be exhaustive and may be under-representative of the actual frequencies. 
 
The centers largely agree that memory, language, attention and executive functions need to 
be assessed as part of a surgical evaluation. There is also agreement about using 
normalized and standardized tests, employing either national or international normative data. 
Few clinics use their own unpublished norms.  
 please insert here:  Table 2. Neuropsychology: who, why, what - and what for?  
 
Neuropsychological assessment for pediatric patients is provided in 76% of the centers 
(Table 1). Of 18 valid answers, the majority of centers use standardized developmental 
scales or tests already in babies and toddlers (Table 3). Of 23 centers offering in-house 
surgery, 19 (83%) provide a surgical program for children. Of those, 17 provide 
neuropsychological assessment for children. Two centers provide neuropsychological 
assessment for children but do not offer in-house surgery at all (1) or not for children (1). 
 
please insert here:  Tab.3: Use of standardized tools for pediatric patients given in percentages 
 
 
3.3. Which test instruments are currently used? Neuropsychological tests and questionnaires 
 
With a total number of 168 different tests and procedures in use in children and adults, the 
variation in neuropsychological diagnostics between centers was considerable. Table 4 lists 
only those tests which are used by at least 3 centers. Multiple answers were possible for 
each domain. Tests are listed separately for children and adults. Concerning children, the 
results showed that development and IQ play an important role. Performance testing of is 
nevertheless also an issue in children and adolescents. Table 5 provides the source for 
justifying the selection of this specific test. As for references for the different tests see 
compendia like [30, 31] or see the websites of Pearson Assessment 
(http://www.pearsonassessment.de/), publisher Hogrefe (http://www.testzentrale.de/) and 
Psytest (http://www.psytest.net/index.php?page=TAP-2-2&hl=en_US).  
 
For testing of intelligence, among 7 different scales, the Wechsler Scales for children and 
adults was used in all except one center. For adults, either full (90%) and/or abbreviated 
versions (15%) are employed. In all three participating German-speaking centers, a 
vocabulary test is used for assessing crystallized and education dependent intelligence in 
adults (Mehrfachwahl-Wortschatz-Intelligenztest, MWT-B). For children, Wechsler scales for 
school (60%) or preschool (33%) age are applied. 
For developmental diagnostics, the most popular scale is the Bayley Scales of Infant 
Development (33%), while some centers use the Denver Developmental Screening test or, to 
measure adaptive behavior, the Vineland Adaptive Behaviour Scale (VABS) or the (20% 
each).  
For nonverbal memory functions, 10 different tests are in use. The Rey-Osterrieth 
Complex Figure test (ROCFT) is used most frequently (55%) followed by only a few centers 
using the Diagnosticum für Cerebralschädigung (DCS-R) and Benton test. As for verbal 
memory functions, among 12 different tests, the Rey Auditory Verbal Learning Test is used 
frequently (RAVLT, 40% adults, 20% children), followed by the Logical Memory subtest of 
the Wechsler Memory Scale (WMS-R) for adults. Complete memory batteries are rarely used 
(WMS and Recognition Memory Test, RMT). 
For children, no consensus of more than two centers was achieved for memory testing. Most 
frequently used are the DCS-R and as well the RAVLT (20% each). 
Short-term and working memory are tested with the Digit Span and Corsi Block-Tapping 
test by 70% of the centers for adults. These tests are also popular in children (27% block 
tapping, 40% digit span).  
As for attentional functions, Trail Making Test (TMT) is applied by more than half of the 
centers for testing visual psychomotor speed and task switching. Other, less frequently used 
attentional tests in adults are the letter cancellation test D2 (Aufmerksamkeitsbelastungstest) 
in adults (30%) and the Testbatterie zur Aufmerksamkeitsprüfung (TAP, 15%). Executive 
functions are assessed by the Stroop paradigm (45%) or Wisconsin Card Sorting Test 
(WCST, 15%). Agreement for children however is lower, with only TMT reaching a 
consensus of 27%. More popular (33%) is the use of subtests from the Developmental 
Neuropsychological Assessment (NEPSY), which is also used for memory (2 centers), 
language (2 centers), motor (2 centers) and visuospatial functions (1 center).  
27 different language tests are in use. The majority of centers (75% for adults, but only 33% 
for children) are using the Boston Naming Test, which is a word finding test. Although there 
was some critique uttered in our surveys (obsolete items, items dependent on education), 
there is no established alternative test so far. Additionally, many centers assess phonemic 
(45%) and/or semantic (40%) fluency for adults. As for receptive language functions, the 
subtest “token test” from the Aachener Aphasietest (AAT) is used widely (35% for adults, 
33% for children).  
Visuospatial function is assessed by 21 different tests, with little overlap. The most popular 
test is the copy trial of the ROCFT (35%) which itself is also used as a figural memory test. 
All other tests are employed by 20% (Wechsler block design, line orientation) or 15% of 
centers (Hooper Visual Organization Test (VOT), Visual Object and Space Perception 
Battery, VOSP, Benton facial recognition). In children, little agreement (20%) was found for 
the Developmental Test of Visual-Motor Integration (Beery VMI). 
As for motor function, 18 different tests are in use. Agreement was low for adults and non-
existent for children. For adults, the most popular are the finger tapping (25%), Luria 
Sequences (25%) and the Purdue Pegboard (15%). For children, no consensus in at least 3 
centers was found. 
The monitoring of emotions and behavior plays a crucial role in patients with epilepsy, 
given the high incidence of depression, anxiety, aggressive behavior and organic brain 
syndrome due to the epilepsy alone or its treatment.  In adults, the Beck’s Depression 
Inventory (BDI or BDI-II) is used in 60% of the clinics, followed by the Hospital Anxiety and 
Depression Scale (HADS) (25%), Symptom Checklist 90-R (SCL 90-R, 20%), Minnesota 
Multiphasic Personality Inventory (MMPI, 20%) and Beck Anxiety Inventory (BAI (15%)). For 
children, most frequently named was the Child Behavior Checklist (CBCL), used by 20% of 
the centers. 
The ultimate goal of treating epilepsy is improving the individual quality of life. For adults, in 
45% of the centers, the Quality Of Life in Epilepsy Inventory (QOLIE) is used in different 
versions (QOLIE-10, QOLIE-31, QOLIE-89). In three centers, the Short Form 36 (SF 36) is 
used, and three other inventories in single clinics. No agreement was found for pediatric 
assessment. 
 
please insert here:  Tab.4a: Tests used in the different centers for children and adolescents 
 
The normative data of tests and questionnaires used in the centers are mostly a variation of 
published national (92%), international (79%) or local data (33%). Some centers use 
unpublished local normative data (16%). In general, only 52% of the centers (n=13) provided 
us with sources for these normative data (for children and adults). Sources for validity (proof 
that the tests measures what it intends to measure) were provided by 40% (n=10) of the 
respondents. However, these sources were not always specific for use in patients with 
epilepsy. Only 5 centers (20%) provided sources with proven evidence for use of the tools in 
patients with epilepsy. Another 5 stated that all tests are evidence-based but without citing 
any sources. We evaluated each of these sources given for validity in detail, considering only 
sources for those tests that are used by at least 3 centers. For adults, 38 sources were given 
for validity. These stem from the manual in 36.8% of given references, from epilepsy-
unspecific publications in 55.3% and from publications in epilepsy by 7.9%. Except for one 
WAIS reference, the latter references were again in regard to the QOLIE inventory. In regard 
to children and adolescents, as for the validity of the tests in general or in epilepsy, 12 
sources were given. 58.3% of these sources were test manuals, 8.3% publications apart 
from epilepsy and 33.3% epilepsy-related publications.  
 
In response to the question which areas of assessment would require further improvement, 
several aspects were indicated. These included more national norm data, a better test for the 
assessment of nonverbal memory in relation to right temporal lobe epilepsy, time efficient 
tests because of limited personal ressources, RAVLT and DCS co-normalization norms for 
comparison of lateralized temporal lobe functions and updated QOL questionnaires. Another 
question asked if there were any un-captured functions or behaviors seen in the patients for 
which a test would be desired. Suggestions were made for evaluating accelerated long-term 
forgetting, frontal lobe dysfunctions, divided visual field evaluation, every day performance 
and external validity of objective performance, mood and behavioral aspects (panic disorder, 
reaction to stress, organic brain syndrome, social cognition), and a qualitative scoring of test 
performance (type of mistakes, performance pattern). Although some tests would allow a 
more detailed analysis, corresponding scores are not yet part of a standard diagnostic 
routine and there is a need for further validation and standardization of these measures. 
 
 
3.4. Assessment of hemispheric dominance 
 
Assessing the dominant hemisphere for language functions is mostly performed by fMRI (in 
91%) and IAT (59%), combined with lateralizing tests (91%) such as verbal vs. nonverbal 
memory and inventories (handedness) (Table 5). In single centers, Transcranial Magnetic 
Stimulation (TMS), Magnetoencephalograpy (MEG) and Diffusion Tensor Imaging (DTI) 
(arcuate tract) is performed for some cases. Functional transcranial Doppler sonography 
(fTCD) is used by two centers on a regular basis, with approximately n=33 and n=51 patients 
per year, one center using the “Bishop Picture Animation Paradigm” and one center using a 
word generation and picture description task. 
 
please insert here:  Table 5. Methods for assessing hemispheric dominance for language functions 
 
The IAT, although long regarded as the gold standard for evaluation of hemispheric 
dominance, has increasingly been replaced by noninvasive methods [32]. The indications 
differ among the centers (Table 6), from performing the IAT in all cases of TLE of the 
dominant hemisphere to cases only with the epileptogenic focus in or adjacent to eloquent 
cortex (n=5). As for the general approach, bilateral injection in the ACI is still the standard 
procedure. Anesthetics differ among the centers as well, with amobarbital used most 
frequently (69%) but in some cases, propofol or methohexital.  
 
Please insert here:  Table 6. Protocols and methods for performing functional magnetic resonance 
imaging and the intracarotid amobarbital test for assessing the hemispheric dominance for 
language functions 
 
Out of 20 participants with valid answers concerning fMRI, 20% always perform fMRI in 
presurgical patients, 55% perform fMRI if the resection is planned in or adjacent to an 
eloquent areal, 50% if atypical dominance is suspected, 30% if the to-be-resected lesion is 
located in the (presumably) dominant hemisphere, and 5% perform fMRI in bitemporal cases 
(multiple answers were possible). Most centers use two (42%) or three language paradigms 
(37%), the minority use only one paradigm (21%). Paradigms are mostly word generation 
(79%), followed by naming (42%), semantic comparisons (37%), listening (32%) and reading 
(26%). Hemispheric dominance is assessed purely visually (50%, n=7) or additionally with a 
lateralization index (50%). Of the centers that use fMRI on a regular basis, SPM is most often 
used for analysis (54%, 7 centers), other programs were used by one (FSL, BrainVoyager, 
BrainWave, Neuro3D) or two centers each (NordicBrainEx). Only two out of 25 centers 
provided the requested decision tree in this regard.  
 
4. Discussion 
Our survey collected information about the practice of neuropsychological assessments in 25 
epilepsy centers and confirms that neuropsychological assessment is generally perceived as 
an essential part of the pre- and postsurgical work-up in children, adolescents and adults.  
In most E-PILEPSY associated centers, neurosurgery and neuropsychology are performed 
in-house or close by, so that the conditions are optimal for short communication pathways 
and multi-disciplinary patient care.  
According to the survey, major indications for neuropsychological evaluations are the 
assessment of the general performance level, assessment of partial functions as well as ictal 
and postictal testing for localization diagnostics (relationships of structure and focus to 
function), determination of language dominance, negative cognitive antiepileptic drug effects, 
postsurgical follow-up and outcome control, and indication for rehabilitative care. In children, 
evaluation and monitoring of neurodevelopment is also a major indication. As for the 
structural and methodological aspects of neuropsychological assessment in epilepsy, the EU 
centers largely are in line with recent recommendations by the ILAE neuropsychology task 
force [20].  
In times of limited personnel capacity (neuropsychological staff consists on average of 2.5 
psychologists, with an average number of 171 patients tested per year and an average time 
of 4.5 hours for a presurgical evaluation, see Table 2.), it seems impossible to perform a 
thorough neuropsychological assessment with every patient receiving all tests and 
procedures. Instead a core test battery should be compiled which can be extended optionally 
depending on specific questions in terms of a modular diagnostics.  
 
Looking at the domains that the centers rated as most essential there was a high consensus 
(64-90%) regarding the necessity to assess memory, language, attention and executive 
functions. The order of the listing corresponds to the fact that most surgical candidates have 
temporal lobe epilepsy (memory & language) followed by frontal and posterior epilepsies 
(attention, executive functions, language, visuo-construction, motor functions). Tests for 
primary and secondary posterior perceptual (optical, auditory, tactile functions) were largely 
not considered and are probably less relevant. IQ interestingly was considered as necessary 
by less than one third of the centers for children and adults (5/18, 27.8%), but for 75% (3/4) 
of centers testing only children. In young children developmental scales are widely used, and 
assess the major domains of psychomotor, cognitive and language development. Partial 
functions are relevant in children as well but as we know from the literature, localization and 
lateralization diagnostics are difficult when examining the not yet developed and specialized 
brain [1].  
 
The overall number of all tests and questionnaires was vast (n=168). However, following 
frequency statistics, good candidates for a core battery on which centers might agree could 
be found for most domains (see result section, 3.3). This selection is not meant to be a 
recommendation, but rather a reflection of the current practice. This is highly dependent on 
the availability of the individual tests in the specific countries or languages, and does not 
necessarily reflect the degree of evidence for the use of the tools in patients with epilepsy. 
For some countries, some consensus might already exist on a national level. In Germany, a 
working group with all neuropsychologists in epilepsy centers as well as a working group for 
presurgical diagnostics and epilepsy surgery associated with the national ILAE chapter has 
been established which meet at regular intervals and which are dedicated to harmonizing 
and improving assessments in Germany [27, 28, 33].  
 
Neuropsychological assessment should not be an end in itself. It should provide information 
about the patients that is useful for clinical decision making. Neuropsychological testing was 
noted to be important in decision-making by influencing therapeutic decisions, counseling of 
patients in regard to possible cognitive sequels of surgery as well as determining the extent 
and timing of the surgery. Apart from the presurgical work-up per se, neuropsychology also 
helps to optimize treatment with AEDs, indicates the necessity to assess language 
dominance in cases of atypical memory profiles, leads to referrals to rehabilitation programs 
in case of significant postsurgical impairments, indicates the necessity of psychiatric care 
and treatment in cases of severe depression, psychosis, or mental decline/dementia, or 
indicates the initiation and/or termination of immune-modulatory therapies (in cases auf auto-
immune encephalitis). Apart from exhaustive assessment, postictal testing of basic cognitive 
functions is one important aspect of presurgical diagnostic, indicating side or site of 
epileptogenic seizure focus [32]. This includes testing of language functions for lateralization 
of seizure origin. 
 
Given these consequences of neuropsychological evaluations for patients and treatment 
decisions, it is well understood that the tests in use are valid and reliable in people with 
epilepsy. Purely performance-orientated testing does not necessarily meet the requirements 
of a sophisticated presurgical evaluation in epilepsy patients and might even be irresponsible 
if such non-specific knowledge is used for counseling, or when expected or predictable 
deficits cannot be detected or predicted. As a well-known example, with only IQ testing 
performed in the amnestic patient H.M. the catastrophic outcome of bilateral amygdalo-
hippocampectomy would have been missed [34].  
This was the reason all centers were asked to cite the sources which would demonstrate the 
validity of the used tests in regard to detecting the effects of epileptogenic lesions, 
seizures/epileptic activity, epilepsy surgery and pharmacological treatment. Here many 
sources were cited concerning the normalization and general validity of the tools used, i.e. 
that a memory test is indeed measuring memory and that it has age-based norms etc., but 
surprisingly few references were given addressing the validity of these tests in epilepsy. 
Either this means that the test selection is not based on evidence for the use in epilepsy, that 
there is no evidence, or that this question was skipped because lack of time, or simply 
because of a limited number of adequate tests available in certain centers. 
Whatever the reason for the present results may be, the results parallel those of a national 
survey [24] which showed that only one third of the tests were evidence-based for use in 
epilepsy, another third by the fact that the tests are well normalized and standardized 
independent of epilepsy, and one third by personal preferences.  
 
The second part of this study addressed hemispheric dominance assessment. It showed a 
high agreement on the methods in use. Almost all centers use fMRI in addition to lateralizing 
cognitive tests and handedness inventories. Many centers still use the IAT [35] but only in 
single selected cases and not as part of standard care. Generally there appears to be some 
uncertainty regarding the individual use and application of measures for the determination of 
dominance tests. This is at least indicated by the lack of agreement on the circumstances 
which would indicate the necessity of IAT and fMRI, reflecting what these methods are really 
good for. The rare use of the IAT reflects the steady decline of indications for the IAT which 
is reported in the literature. The remaining few cases probably show when this information is 
really indispensable and what this method is able to tell and predict. The future of fMRI and 
other methods and their value for presurgical diagnostics needs to be further explored. 
 
Conclusion 
 
The general principles of neuropsychological testing were evaluated across Europe and are 
consistent as such with what has recently been formulated by the neuropsychology task 
force of the ILAE [20]. This is encouraging since this knowledge provides a foundation that 
will inform future recommendations on which tests (minimum standards) should be used in 
the pre- and post-surgical care of persons with epilepsy. Similar to Marilyn Jones-Gotman’s 
milestone work 23 years ago [21] however, there is still significant heterogeneity between 
centers in regards to the tests that are used. Nevertheless a subset of tests can be 
highlighted for the most essential cognitive and behavioral domains that appear to be good 
candidates for a core battery across the E-PILEPSY associated centers. Since only a 
minority of the tests in use had been or could be justified on the basis of published evidence, 
the essence of the survey shows that the final selection of tests will need to be based on the 
best evidence (ongoing systematic review), the current survey and for many, based on 
expert consensus methodology (until further evidence is available). Finally, as regards to the 
assessment of hemispheric dominance, lack of common paradigms raises the question as to 
when these results are really essential for clinical decision making. Here additional work is 
required to compare methods and paradigms to reveal the exact way of decision making in 
the individual patient.  
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